Cargando…
Macular hole retinal detachment after intravitreal Conbercept injection for the treatment of choroidal neovascularization secondary to degenerative myopia: a case report
BACKGROUND: We report a case of macular hole (MH) formation and retinal detachment after intravitreal conbercept injection for the treatment of choroidal neovascularization (CNV) secondary to degenerative myopia. CASE PRESENTATION: A 60-year-old woman presented with blurred vision in her left eye wa...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6647155/ https://www.ncbi.nlm.nih.gov/pubmed/31331298 http://dx.doi.org/10.1186/s12886-019-1164-4 |
_version_ | 1783437668071243776 |
---|---|
author | Sun , Chuan-bin Wang, Yueye Zhou, Shiyang Fang, Xudong Xu, Danni Liu, Zhe |
author_facet | Sun , Chuan-bin Wang, Yueye Zhou, Shiyang Fang, Xudong Xu, Danni Liu, Zhe |
author_sort | Sun , Chuan-bin |
collection | PubMed |
description | BACKGROUND: We report a case of macular hole (MH) formation and retinal detachment after intravitreal conbercept injection for the treatment of choroidal neovascularization (CNV) secondary to degenerative myopia. CASE PRESENTATION: A 60-year-old woman presented with blurred vision in her left eye was diagnosed as CNV secondary to degenerative myopia. Intravitreal injection of conbercept, an anti -vascular endothelial growth factor (VEGF) agent, was uneventfully performed in the left eye. Unfortunately, a full thickness MH and retinal detachment was found three weeks postoperatively by ophthalmoscopy and spectral-domain optical coherence tomography. Vitrectomy, internal limiting membrane peeling and silicone oil tamponade were then performed, and macular retina was reattached soon after surgery. However, MH still kept open during three months’ follow-up. CONCLUSION: MH is a quite rare complication of intravitreal anti- VEGF agent injection, tangential contraction secondary to CNV shrinkage and regression caused by anti-VEGF agent is proposed to be the major pathogenesis of MH formation. |
format | Online Article Text |
id | pubmed-6647155 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-66471552019-07-31 Macular hole retinal detachment after intravitreal Conbercept injection for the treatment of choroidal neovascularization secondary to degenerative myopia: a case report Sun , Chuan-bin Wang, Yueye Zhou, Shiyang Fang, Xudong Xu, Danni Liu, Zhe BMC Ophthalmol Case Report BACKGROUND: We report a case of macular hole (MH) formation and retinal detachment after intravitreal conbercept injection for the treatment of choroidal neovascularization (CNV) secondary to degenerative myopia. CASE PRESENTATION: A 60-year-old woman presented with blurred vision in her left eye was diagnosed as CNV secondary to degenerative myopia. Intravitreal injection of conbercept, an anti -vascular endothelial growth factor (VEGF) agent, was uneventfully performed in the left eye. Unfortunately, a full thickness MH and retinal detachment was found three weeks postoperatively by ophthalmoscopy and spectral-domain optical coherence tomography. Vitrectomy, internal limiting membrane peeling and silicone oil tamponade were then performed, and macular retina was reattached soon after surgery. However, MH still kept open during three months’ follow-up. CONCLUSION: MH is a quite rare complication of intravitreal anti- VEGF agent injection, tangential contraction secondary to CNV shrinkage and regression caused by anti-VEGF agent is proposed to be the major pathogenesis of MH formation. BioMed Central 2019-07-22 /pmc/articles/PMC6647155/ /pubmed/31331298 http://dx.doi.org/10.1186/s12886-019-1164-4 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Case Report Sun , Chuan-bin Wang, Yueye Zhou, Shiyang Fang, Xudong Xu, Danni Liu, Zhe Macular hole retinal detachment after intravitreal Conbercept injection for the treatment of choroidal neovascularization secondary to degenerative myopia: a case report |
title | Macular hole retinal detachment after intravitreal Conbercept injection for the treatment of choroidal neovascularization secondary to degenerative myopia: a case report |
title_full | Macular hole retinal detachment after intravitreal Conbercept injection for the treatment of choroidal neovascularization secondary to degenerative myopia: a case report |
title_fullStr | Macular hole retinal detachment after intravitreal Conbercept injection for the treatment of choroidal neovascularization secondary to degenerative myopia: a case report |
title_full_unstemmed | Macular hole retinal detachment after intravitreal Conbercept injection for the treatment of choroidal neovascularization secondary to degenerative myopia: a case report |
title_short | Macular hole retinal detachment after intravitreal Conbercept injection for the treatment of choroidal neovascularization secondary to degenerative myopia: a case report |
title_sort | macular hole retinal detachment after intravitreal conbercept injection for the treatment of choroidal neovascularization secondary to degenerative myopia: a case report |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6647155/ https://www.ncbi.nlm.nih.gov/pubmed/31331298 http://dx.doi.org/10.1186/s12886-019-1164-4 |
work_keys_str_mv | AT sunchuanbin macularholeretinaldetachmentafterintravitrealconberceptinjectionforthetreatmentofchoroidalneovascularizationsecondarytodegenerativemyopiaacasereport AT wangyueye macularholeretinaldetachmentafterintravitrealconberceptinjectionforthetreatmentofchoroidalneovascularizationsecondarytodegenerativemyopiaacasereport AT zhoushiyang macularholeretinaldetachmentafterintravitrealconberceptinjectionforthetreatmentofchoroidalneovascularizationsecondarytodegenerativemyopiaacasereport AT fangxudong macularholeretinaldetachmentafterintravitrealconberceptinjectionforthetreatmentofchoroidalneovascularizationsecondarytodegenerativemyopiaacasereport AT xudanni macularholeretinaldetachmentafterintravitrealconberceptinjectionforthetreatmentofchoroidalneovascularizationsecondarytodegenerativemyopiaacasereport AT liuzhe macularholeretinaldetachmentafterintravitrealconberceptinjectionforthetreatmentofchoroidalneovascularizationsecondarytodegenerativemyopiaacasereport |